Early and adequate antibiotic therapy in the treatment of severe sepsis and septic shock (Q44658786)

5 December 2017

title

Early and adequate antibiotic therapy in the treatment of severe sepsis and septic shock (English)

1 reference

5 December 2017

0 references

0 references

1 reference

2

Marin H Kollef

1 reference

5 December 2017

John D Dickinson

1

1 reference

5 December 2017

publication date

1 October 2011

1 reference

Current infectious disease reports

5 December 2017

published in

1 reference

5 December 2017

volume

13

1 reference

5 December 2017

issue

5

1 reference

5 December 2017

page(s)

399-405

1 reference

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Sepsis in European intensive care units: results of the SOAP study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

The epidemiology of sepsis in the United States from 1979 through 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Epidemiology of sepsis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Relationship of clinical presentation to time to antibiotics for the emergency department management of suspected bacterial meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Bundled care for septic shock: an analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Antimicrobial management of sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Suboptimal aminoglycoside dosing in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Pharmacodynamics of cefepime in patients with Gram-negative infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Improved survival of critically ill cancer patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0206-8

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock

21 January 2018

1 reference

12 December 2020

Before-after study of a standardized hospital order set for the management of septic shock

1 reference

12 December 2020

Evolution of antibiotic therapy for infection in neutropenic patients: studies at M. D. Anderson Hospital

1 reference

12 December 2020

Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis

1 reference

12 December 2020

Adverse outcome of bacterial meningitis due to delayed sterilization of cerebrospinal fluid

1 reference

12 December 2020

1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Comm

1 reference

12 December 2020

Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I

1 reference

12 December 2020

1 reference

12 December 2020

Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients

1 reference

12 December 2020

Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections

1 reference

12 December 2020

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock

1 reference

12 December 2020

10.1007/S11908-011-0206-8

Identifiers

DOI

1 reference

5 December 2017

1 reference